Assay ID | Title | Year | Journal | Article |
AID1218469 | Drug metabolism in human liver microsomes assessed as IC50 for ritonavir-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218461 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2A inhibitor 8-methoxypsoralen | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218521 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP1A1 inhibitor alpha-naphthoflavone | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218462 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2A inhibitor 8-methoxypsoralen | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218505 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes treated with 2 to 40 uM of 1alpha,25(OH)2D3 by Michaelis-Menten equation analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218492 | Drug metabolism in prednisone treated CD1 mouse liver microsomes treated with 20 uM of 1alpha,25(OH)2D3 assessed as metabolite formation after 30 mins by LC/MS analysis in presence of NADPH | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218518 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP1A2 inhibitor furafyline | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218470 | Drug metabolism in human liver microsomes assessed as IC50 for ketoconazole-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218466 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as 1 uM CYP3A inhibitor-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218475 | Drug metabolism in human liver microsomes assessed as 1.24 uM docetaxel-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218472 | Drug metabolism in human liver microsomes assessed as IC50 for tamoxifen-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218478 | Drug metabolism in human liver microsomes assessed as 10 uM paclitaxel-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218526 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2C inhibitor sulfaphenazole | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218508 | Activity at human recombinant CYP3A4 treated with 2 to 40 uM of 1alpha,25(OH)2D3 by Michaelis-Menten equation analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218507 | Drug metabolism in human liver microsomes treated with 2 to 40 uM of 1alpha,25(OH)2D3 by Michaelis-Menten equation analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218463 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2B inhibitor orphenadrine | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218468 | Drug metabolism in CD1 mouse liver microsomes assessed as 1 uM CYP3A inhibitor-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218460 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2A inhibitor 8-methoxypsoralen | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218519 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP1A2 inhibitor furafyline | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218520 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP1A2 inhibitor furafyline | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218477 | Drug metabolism in human liver microsomes assessed as 100 uM tamoxifen-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218528 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2D inhibitor quinine | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218465 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2B inhibitor orphenadrine | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218467 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as 1 uM CYP3A inhibitor-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218457 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2E inhibitor di-ethyldithiocarbamate | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218481 | Drug metabolism in human liver microsomes assessed as 100 uM chloramphenicol-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218522 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP1A1 inhibitor alpha-naphthoflavone | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218476 | Drug metabolism in human liver microsomes assessed as 10 uM ritonavir-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218527 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2D inhibitor quinine | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218471 | Drug metabolism in human liver microsomes assessed as IC50 for clarithromycin-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218499 | Drug level in dexamethasone treated CD1 mouse liver microsomes treated with 20 uM of 1alpha,25(OH)2D3 after 30 mins by LC/MS analysis in presence of NADPH relative to vehicle treated mouse | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218523 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP1A1 inhibitor alpha-naphthoflavone | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218458 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2E inhibitor di-ethyldithiocarbamate | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218493 | Drug level in human liver microsomes assessed as retention time treated with 20 uM of 1alpha,25(OH)2D3 after 30 mins by LC/MS analysis in presence of NADPH | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218525 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2C inhibitor sulfaphenazole | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218464 | Drug metabolism in dexamethasone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2B inhibitor orphenadrine | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218473 | Drug metabolism in human liver microsomes assessed as IC50 for docetaxel-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218474 | Drug metabolism in human liver microsomes assessed as 1 uM ketoconazole-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218506 | Drug metabolism in prednisone treated CD1 mouse liver microsomes treated with 2 to 40 uM of 1alpha,25(OH)2D3 by Michaelis-Menten equation analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218524 | Drug metabolism in prednisone treated CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2C inhibitor sulfaphenazole | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218479 | Drug metabolism in human liver microsomes assessed as 100 uM clarithromycin-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218480 | Drug metabolism in human liver microsomes assessed as 100 uM troleandromycin-mediated inhibition of metabolite formation at 20 uM after 30 mins by LC/MS analysis | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218459 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2E inhibitor di-ethyldithiocarbamate | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
AID1218529 | Drug metabolism in CD1 mouse liver microsomes assessed as metabolite formation at 20 uM after 30 mins by LC/MS analysis in presence of NADPH and CYP2D inhibitor quinine | 2012 | Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 40, Issue:5
| Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |